Chito-Gluko Fit G

Researchers have shown that the substances discovered are polymeric inhibitors. They were created on the basis of chitosan – a compound obtained from marine crustaceans. The effect of the polymer is that it binds to the protein that forms the “crown” of the virus and blocks its interaction with the cell receptor, and consequently the entry of the virus into the cell.

Chitosan, from which polymeric compounds are obtained, is chemically an organic compound of the polysaccharide group; a derivative of chitin, formed by its partial deacetylation. Deacetylation of chitin involves the removal of acetyl groups from chitin, which harden and cement chitin. The highest biochemical activity of chitosan is obtained when it is processed through the patented OCHG™ process. The result is chitosan lactate or chitosan in the form of oligomers, or polymers, with short chains and a well-defined molecular weight. Structurally, chitosan is a cellulose (fiber) of animal origin, similar to human fibrin. It is completely natural and well tolerated by our body. Chitosan has a very beneficial effect on the entire body. Experts call it the sixth essential component of life after proteins, fats, sugars, minerals and vitamins. It effectively purifies and deacidifies the body, stimulates the human defense mechanisms, does not allow cancer cells to multiply, lowers cholesterol, helps reduce body weight. With the help of chitosan it is possible to overcome many diseases with which modern medicine cannot cope.

CHITOZIN FIT C contains liquid chitosan lactate in the form of oligomers. It is characterized by very high bioavailability and biochemical activity, which gives it the highest effectiveness among other known products containing chitosan.

Experimental studies confirm the antimicrobial mechanism of action of chitosan. It is related to the breakdown of the cell wall structure due to free amino groups present in chitosan. The positively charged chitosan interacts with the negatively charged chemical bonds in the cell wall of bacteria or viruses, causing them to break down. This occurs through electrostatic forces acting between protonated amino groups and negative residues, competing for electro-negative sites on the surface of the microbial cell membrane. This interaction alters permeability of the cell membrane, and contributes to its breakdown and leakage of intracellular matter. Other studies suggest that a polymeric envelope forms around the cell membrane of microorganisms, that is, chitosan forms a kind of shell over the microorganism cell that prevents nutrients from entering that cell. Another discovered mechanism of action of Chitosan is the binding of chitosan molecules to microbial or viral DNA, which leads to inhibition of mRNA and protein synthesis. Chitosan molecules have been shown to be able to penetrate the cell wall of bacteria and reach their genetic material.

It works on all organs, improves the general condition of the body, raising the pH to 7.35 – 7.4. deacidifies the body. Acidification of the body disrupts all biochemical processes of the body, thickens the blood, disrupts circulation, puts a great strain on the kidneys, causes joint and muscle pain, and promotes the growth of cancer cells. In an alkaline environment, cancer cells do not reproduce. Therefore, chitosan used in higher doses causes cancer cell death and reduces the size of tumors

Chitosan cleanses the digestive tract, liver and entire body of heavy metals and toxins by binding and excreting them from the body. Research results indicate that it is very effective in improving the condition and function of the liver and pancreas. Chitosan also binds chlorine ions from table salt and excretes them, which prevents the production of angiotensin, a substance that causes rapid vasoconstriction. As a result, it has a hypotensive effect, lowering blood pressure. The formula binds and excretes cholesterol from the gastrointestinal tract because it has positively charged amino groups at the same pH as the gastrointestinal tract. The amino groups bind to negatively charged molecules such as lipids and bile, preventing their absorption and storage by the body. The action of chitosan in lowering LDL cholesterol can be explained by the theory that chitosan salts react with fatty acids and bind lipids by a mechanism of hydrophobic interaction. The lipids so bound are excreted from the gastrointestinal tract along with other metabolic products, rather than being reabsorbed as if they occurred naturally.

When it dissolves, a coating is formed which acts as a shield, eliminates hyperacidity, stimulates healing processes, heals erosions, ulcers and mucosal defects. Mucosal defects are the cause of Leaky Gut Syndrome. Leaky Gut Syndrome is one of the main causes of allergies and autoimmune diseases, because undigested nutrients (e.g. casein, gluten) and toxins, penetrate through holes in the intestinal mucosa, enter the bloodstream and consequently trigger an immune response from the immune system

Leaky gut syndrome is often caused by Candida yeast. Candida albicans is a parasitic fungus that lives in the human digestive tract. If there is dysbiosis, or a disruption in the normal composition of the intestinal microbiota, candida begins to proliferate and dominate. As a result, they secrete a number of toxins and metabolites that enter the bloodstream and poison the entire body. This adversely affects a number of processes in the body, disrupts its functioning leading to diseases, including cancer. Chitosan oligomers effectively inhibit Candida.

Hyaluronic acid is also a major component of joint synovia. It is responsible for the viscosity of the synovium, lubricating joint surfaces and nourishing cartilage. Therefore, chitosan used for longer periods of time improves joint mobility.

CHITOZIN FIT C should not be used by people allergic to shellfish. It is also not recommended for children under 12 years of age. It is necessary to keep a 2-hour break between taking the preparation containing chitosan and other used preparations and medicines, because it is an absorbent and may reduce their assimilation.

Take 3 times a day, 5 ml (teaspoon) per ½ glass of water, preferably morning and evening and before food.

For preventive purposes 1-2 months 2-3 times a year.

Yoshinori Tanaka, Shin-ichiro Tanioka, Miyoko Tanaka Effects of chitin and chitosan particles on BALB/c mice by oral and parenteral administration. Biomateriały 18 (1997) 591-595.

Majeti N.V. Ravi Kumar A reviev of chitin and chitosan applications. Reactive & Functional Polymers 46 2000) 1-27.

Alemdaroglu C., Zelihagul D., Celebi N., Zor F., Ozturk S., Erdogan D. 2006. An investigation on burn wound healing in rats with chitosan gel formulation containg epidermal growth factor. Burns 32, s. 219-327.

Ignacak J., Wiśniewska-Wrona M.,Pałka I.,Zagajewski J., Niekraszewicz A. 2011. Rola oligomerów chitozanowych w regulacji proliferacji komórek nowotworowych wodobrzusza Ehrlicha in vitro. Progress on chemistry and application of chitin and its derivatives, Monografia, t. XVI, Polskie Towarzystwo Chitynowe, s. 89.

Ravi Kumar N. V. 2000. A review of chitin and chitosan applications. Reactive & Functional Polymers, 46, s.1-27.

Muzzarelli R.A.A., Muzzarelli C. 2005. Chitosan Chemistry: Relevance to the Biomedical Science. Springer Heidelberg, Berlin.

Ming-Tsung Y., Joan-Hwa Y., Yeng-Leun M. 2008. Antioxidante properties of chitosan from crab shells. Carbohydrate Polymers, 74,4, s.840-844.

Obara K., Ishihara M., Ishizuka T., Fujita M., Ozeki Y., Maehara T., Saito Y.,Yura H., Matsui T., Hattori

H., Kikuchi M., Kurita A. 2003. Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice. Biomaterials, 24, 3437-3444.

Schmitt F., Lagopoulos L., Käuper P., Rossi N., Busso N., Barge J., Wagnières G., Laue C., Wandrey C., Juillerat-Jeanneret L. 2010. Nanożele na bazie chitozanu do selektywnego dostarczania fotouczulaczy do Nanożele na bazie chitozanu do selektywnego dostarczania fotouczulaczy do makrofagów i ulepszonej retencji w stawach i terapii stawów. Journal Control Research. 1;144(2):242-50.

Sahm Inan D., Unver Saraydm D. 2013. Investigation of the wound healing effects of chitosan on FGFR3 and VEGF immunlocalization in experimentally diabetic rats. International Journal of Biomedical Materials Research, 1 (1) 1-8.